U.S. Hospice Market Size, Share & Trends Analysis Report By Type, By Location, By Diagnosis, And Segment Forecasts, 2026 - 2033

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Type Segment
  • 1.2.2. Location Segment
  • 1.2.3. Diagnosis Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. U.S. Hospice Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increased awareness of end-of-life care
    • 3.2.1.2. Rising preference for home-based care
    • 3.2.1.3. Rising geriatric population
    • 3.2.1.4. Growing prevalence of chronic conditions
    • 3.2.1.5. Increasing number of hospice centers
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Underutilization of hospice services among population
    • 3.2.2.2. Shortage of workforce
  • 3.2.3. Industry challenges analysis
    • 3.2.3.1. Correct documentation
    • 3.2.3.2. Misconceptions & late referrals
  • 3.2.4. Industry opportunity analysis
    • 3.2.4.1. Initiatives by hospice care centers
    • 3.2.4.2. Adoption of new technologies
• 3.3. Regulatory Framework & Reimbursement Scenario
• 3.4. State-wise Performance Metrics in Hospice Care Delivery in the U.S.
• 3.5. U.S. Hospice Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape
    • 3.5.2.4. Environmental Landscape
    • 3.5.2.5. Legal Landscape
    • 3.5.2.6. Social Landscape

Chapter 4. U.S. Hospice Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Hospice Market Type Movement Analysis
• 4.3. U.S. Hospice Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 4.4. Routine Home Care
  • 4.4.1. Routine home care market estimates and forecasts 2021 to 2033 (USD Million)
• 4.5. Continuous Home Care
  • 4.5.1. Continuous home care market estimates and forecasts 2021 to 2033 (USD Million)
• 4.6. Inpatient Respite Care
  • 4.6.1. Inpatient respite care market estimates and forecasts 2021 to 2033 (USD Million)
• 4.7. General Inpatient Care
  • 4.7.1. General inpatient care market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Hospice Market: Location Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Hospice Market Location Movement Analysis
• 5.3. U.S. Hospice Market Size & Trend Analysis, by Location, 2021 to 2033 (USD Million)
• 5.4. Hospice Center
  • 5.4.1. Hospice center market estimates and forecasts 2021 to 2033 (USD Million)
• 5.5. Hospital
  • 5.5.1. Hospital market estimates and forecasts 2021 to 2033 (USD Million)
• 5.6. Home Hospice Care
  • 5.6.1. Home hospital care market estimates and forecasts 2021 to 2033 (USD Million)
• 5.7. Skilled Nursing Facility
  • 5.7.1. Skilled nursing facility market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Hospice Market: Diagnosis Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Hospice Market Diagnosis Movement Analysis
• 6.3. U.S. Hospice Market Size & Trend Analysis, by Diagnosis, 2021 to 2033 (USD Million)
• 6.4. Dementia
  • 6.4.1. Dementia market estimates and forecasts 2021 to 2033 (USD Million)
• 6.5. Circulatory/Heart
  • 6.5.1. Circulatory/Heart market estimates and forecasts 2021 to 2033 (USD Million)
• 6.6. Cancer
  • 6.6.1. Cancer market estimates and forecasts 2021 to 2033 (USD Million)
• 6.7. Respiratory
  • 6.7.1. Respiratory market estimates and forecasts 2021 to 2033 (USD Million)
• 6.8. Stroke
  • 6.8.1. Stoke market estimates and forecasts 2021 to 2033 (USD Million)
• 6.9. Chronic Kidney Disease
  • 6.9.1. Chronic kidney disease Market estimates and forecasts 2021 to 2033 (USD Million)
• 6.10. Others
  • 6.10.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Position Analysis, 2025
• 7.4. Company Profiles/Listing
  • 7.4.1. Chemed Corporation (VITAS Healthcare)
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Service benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. LHC Group, Inc. (UnitedHealth Group)
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Service benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Amedisys
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Service benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Gentiva
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Service benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Brookdale Senior Living, Inc
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Service benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Crossroads Hospice (Agape Care Group)
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Service benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Seasons Hospice
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Service benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Oklahoma Palliative & Hospice Care
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Service benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Compassus
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Service benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Chapters Health System
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Service benchmarking
    • 7.4.10.4. Strategic initiatives

List of Tables

• Table 1 List of abbreviations
• Table 2 U.S. Hospice market, by type, 2021 - 2033 (USD Million)
• Table 3 U.S. Hospice market, by location, 2021 - 2033 (USD Million)
• Table 4 U.S. Hospice market, by diagnosis, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Market formulation & validation
• Fig. 4 U.S. Hospice market: Market outlook
• Fig. 5 U.S. Hospice market: Segment outlook
• Fig. 6 U.S. Hospice market: Competitive landscape outlook
• Fig. 7 Parent market outlook
• Fig. 8 U.S. Hospice market driver impact
• Fig. 9 U.S. Hospice market restraint impact
• Fig. 10 U.S. Hospice market: Type outlook and key takeaways
• Fig. 11 U.S. Hospice market: Type movement analysis
• Fig. 12 Routine home care market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 13 Continuous home care market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 14 Inpatient respite care market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 15 General inpatient care market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 16 U.S. Hospice market: Location outlook and key takeaways
• Fig. 17 U.S. Hospice market: Location movement analysis
• Fig. 18 Hospice center market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 19 Hospital market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 20 Home hospice care market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 21 Skilled nursing facility market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 22 U.S. Hospice market: Diagnosis outlook and key takeaways
• Fig. 23 U.S. Hospice market: Diagnosis movement analysis
• Fig. 24 Dementia market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 25 Circulatory/heart market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 26 Cancer market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 27 Respiratory market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 28 Stroke market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 29 Chronic kidney disease market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 30 Others market estimates and forecast, 2021 - 2033 (USD Million)